Chamuleau, R.A.F.M.

Chhatta, A.A.

Deurholt, T.

Hoekstra, R.

Oude Elferink, R.P.J.

Payne, C.

Plevris, J.N.

Sauer, I.M.

Schwartlander, R.

Seppen, J.

ten Bloemendaal, L.

van Til, N.P.

BACKGROUND: A clonal cell line that combines both stable hepatic function and proliferation capacity is desirable for in vitro applications that depend on hepatic function, such as pharmacological or toxicological assays and bioartificial liver systems. Here we describe the generation and characterization of a clonal human cell line for in vitro hepatocyte applications.RESULTS: Cell clones derived from human fetal liver cells were immortalized by over-expression of telomerase reverse transcriptase. The resulting cell line, cBAL111, displayed hepatic functionality similar to the parental cells prior to immortalization, and did not grow in soft agar. Cell line cBAL111 produced urea, albumin, cytokeratin 18 and 19 and showed high glutathione S transferase pi mRNA levels. In contrast to hepatic cell lines NKNT-3 and HepG2, all hepatic functions were expressed in cBAL111, although there was considerable variation in their levels compared with primary mature hepatocytes. When transplanted in the spleen of immunodeficient mice, cBAL111 engrafted into the liver and partly differentiated into hepatocytes showing expression of human albumin and carbamoylphosphate synthetase without signs of cell fusion.CONCLUSION: This novel liver cell line has the potential to differentiate into mature hepatocytes to be used for in vitro hepatocyte applications

UvA-DARE

Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes

Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes

Abstract

Similar works

Full text

Available Versions

UvA-DARE